Ousted Vaccine Chief Says RFK Jr.’s Team Sought Data to Justify Anti-Science Stance
Peter Marks says the new health secretary’s team wants to show vaccines aren’t safe while promoting dangerous and unproven ...
'Decapitated': More top vaccine regulators out at FDA, threatening new approvals
More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...
Dermatology Advisor4h
Top FDA Vaccine Official Quits, Warns of Vaccine Misinformation
Dr Peter Marks is resigning as director of the FDA's Center for Biologics Evaluation and Research by April 5 due to objections to RFK Jr.
Fierce Pharma22h
Amid FDA tumult, agency misses decision deadline on Novavax's COVID shot
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
FDA delays full approval of Novavax COVID-19 vaccine even though it was on track for clearance
The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...
Doctor explains what ‘Make America Healthy Again’ movement is about
“What’s happening … is a reflection of the sprawling bureaucracy that’s actually making America sick and costing hundreds of ...
Dr. Susan Kressly: The dangerous war on vaccines
Against the backdrop of a rapidly expanding measles outbreak, what we need right now is urgent assistance from the federal ...
Just The News23hOpinion
Big Pharma gravy train hits the skids under Trump, panicking revolving-door regulators, investors
Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...
Fierce Pharma3h
FDA staff cuts could disrupt drug reviews, putting agency's critical funding programs at risk: reports
Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to multiple reports.
Bizcommunity on MSN19h
Sanofi-Novavax deal in jeopardy as FDA halts vaccine approval
Dr Sara Brenner, the FDA's principal deputy commissioner, has paused the approval process for Novavax's Covid-19 vaccine by ...
pharmaphorum18h
As gonorrhoea threat grows, Intravacc gets $14m for vaccine hunt
Dutch biotech Intravacc has been given a $14.6 million grant by the US government to develop an intranasal vaccine for gonorrhoea ... although that is a broad-spectrum drug used for many types ...